Acadia Pharmaceuticals
ACAD
ACAD
244 hedge funds and large institutions have $3.61B invested in Acadia Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 86 increasing their positions, 72 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $3.76B → $3.61B (-$150M)
10% less funds holding
Funds holding: 271 → 244 (-27)
40% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 68
Holders
244
Holding in Top 10
3
Calls
$47.5M
Puts
$16.4M
Top Buyers
| 1 | +$66.8M | |
| 2 | +$58.8M | |
| 3 | +$45M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$36.7M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$32.9M |
Top Sellers
| 1 | -$84.1M | |
| 2 | -$41.2M | |
| 3 | -$36.4M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$27.7M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$25.8M |